Консервативное лечение миастении в условиях миастенического центра
Романова Татьяна Валентиновна · Неврология, нейропсихиатрия, психосоматика · 2013
The paper analyzes the results of treatment in 373 patients included in the Samara Region’s register of myasthenia gravis. The average disease duration was 9.7±7.6 years. Treatment encompassed symptom control with acetylcholinesterase inhibitors and immunosuppressive therapy. To achieve remission and good compensation, most cases needed the combined use of anticholinesterase inhibitors and immunosuppression with glucocorticoids and/or cytostatics. The efficiency of glucocorticoid and cytostatic therapies did not differ essentially. The adverse reactions of the treatment were evaluated. Therapy could achieve stabilization and improvement in 88.2% of cases.
Cited by 0 works.
Authors
References
- Meningeal Hemangiopericytoma: Histopathological Features, Treatment, and Long-Term Follow-up of 44 Cases
- Magnetic resonance imaging of meningiomas.
- Intracranial hemangiopericytomas: MR and CT features.
- Primary intracranial meningeal and spinal hemangiopericytoma: radiologic manifestations.
- [Two cases of an intracranial large hemangiopericytoma associated with brain swelling in the early operative stage].